Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387022897> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W4387022897 endingPage "334" @default.
- W4387022897 startingPage "329" @default.
- W4387022897 abstract "Background: Autoimmune blistering disorders are a group of rare skin diseases. They develop when your body's mucous membranes the lining of your mouth, nose, and other cavities and skin are attacked by your immune system. Blisters grow as a result of this. Objective: The main goal of this study is to determine the diagnosis and treatment methods of the autoimmune blistering diseases in Bangladesh. Methods: A cross sectional study was conducted in a total of 260 patients from January 2021 to December 2021 in 250 Bedded General hospital, Jamalpur, Bangladesh. Results: In our study, 55% patients were male and 45% patients were female. Maximum patients (19.6%) were between 30 to 39 years of age group. Minimum number of patients (13.2%) were between 20 to 29 of age group. Maximum patients (75) had pemphigus vulggaris and minimum number of patients (15) had pemphigus foliaceus. Maximum patients were treated with steroids (51) and azathioprine (53). Minimum number of patients (10) were treated with cyclosporine. Side effects like (Cushing syndrome, Growth retardation, Osteoporosis) were observed in patients treated with steroids (6), Neutropenic sepsis (4) in Rituximab, Hemolytic anemia (3) in Dapsone and Nausea (4) in Azathioprine. 141 patients had complete remission off therapy and 119 patients had partial remission on therapy. Conclusion: As the population ages, more people will eventually require treatment for autoimmune skin illnesses that cause blistering. Rituximab, infliximab, etanercept, leflunomide, doxycycline, omalizumab, and immunoadsorption are currently being explored in controlled prospective trials since there is an urgent need for specific and well-tolerated medicines. Prospective, controlled trials are still needed to verify the effectiveness of the present treatments." @default.
- W4387022897 created "2023-09-26" @default.
- W4387022897 creator A5001763666 @default.
- W4387022897 creator A5030408382 @default.
- W4387022897 creator A5034650168 @default.
- W4387022897 creator A5041450783 @default.
- W4387022897 creator A5059369045 @default.
- W4387022897 creator A5081097590 @default.
- W4387022897 date "2023-09-03" @default.
- W4387022897 modified "2023-10-16" @default.
- W4387022897 title "The Diagnosis and Treatment Methods of the Autoimmune Blistering Diseases" @default.
- W4387022897 doi "https://doi.org/10.36349/easms.2023.v06i09.001" @default.
- W4387022897 hasPublicationYear "2023" @default.
- W4387022897 type Work @default.
- W4387022897 citedByCount "0" @default.
- W4387022897 crossrefType "journal-article" @default.
- W4387022897 hasAuthorship W4387022897A5001763666 @default.
- W4387022897 hasAuthorship W4387022897A5030408382 @default.
- W4387022897 hasAuthorship W4387022897A5034650168 @default.
- W4387022897 hasAuthorship W4387022897A5041450783 @default.
- W4387022897 hasAuthorship W4387022897A5059369045 @default.
- W4387022897 hasAuthorship W4387022897A5081097590 @default.
- W4387022897 hasBestOaLocation W43870228971 @default.
- W4387022897 hasConcept C126322002 @default.
- W4387022897 hasConcept C141071460 @default.
- W4387022897 hasConcept C16005928 @default.
- W4387022897 hasConcept C2776760755 @default.
- W4387022897 hasConcept C2777385706 @default.
- W4387022897 hasConcept C2777640609 @default.
- W4387022897 hasConcept C2778248108 @default.
- W4387022897 hasConcept C2779134260 @default.
- W4387022897 hasConcept C2779338263 @default.
- W4387022897 hasConcept C2780653079 @default.
- W4387022897 hasConcept C2781327288 @default.
- W4387022897 hasConcept C2908647359 @default.
- W4387022897 hasConcept C71924100 @default.
- W4387022897 hasConcept C90924648 @default.
- W4387022897 hasConcept C99454951 @default.
- W4387022897 hasConceptScore W4387022897C126322002 @default.
- W4387022897 hasConceptScore W4387022897C141071460 @default.
- W4387022897 hasConceptScore W4387022897C16005928 @default.
- W4387022897 hasConceptScore W4387022897C2776760755 @default.
- W4387022897 hasConceptScore W4387022897C2777385706 @default.
- W4387022897 hasConceptScore W4387022897C2777640609 @default.
- W4387022897 hasConceptScore W4387022897C2778248108 @default.
- W4387022897 hasConceptScore W4387022897C2779134260 @default.
- W4387022897 hasConceptScore W4387022897C2779338263 @default.
- W4387022897 hasConceptScore W4387022897C2780653079 @default.
- W4387022897 hasConceptScore W4387022897C2781327288 @default.
- W4387022897 hasConceptScore W4387022897C2908647359 @default.
- W4387022897 hasConceptScore W4387022897C71924100 @default.
- W4387022897 hasConceptScore W4387022897C90924648 @default.
- W4387022897 hasConceptScore W4387022897C99454951 @default.
- W4387022897 hasIssue "09" @default.
- W4387022897 hasLocation W43870228971 @default.
- W4387022897 hasOpenAccess W4387022897 @default.
- W4387022897 hasPrimaryLocation W43870228971 @default.
- W4387022897 hasRelatedWork W1538904555 @default.
- W4387022897 hasRelatedWork W1947829353 @default.
- W4387022897 hasRelatedWork W1976414724 @default.
- W4387022897 hasRelatedWork W2369686741 @default.
- W4387022897 hasRelatedWork W2888749285 @default.
- W4387022897 hasRelatedWork W2919709798 @default.
- W4387022897 hasRelatedWork W3192664601 @default.
- W4387022897 hasRelatedWork W4213031211 @default.
- W4387022897 hasRelatedWork W4226197543 @default.
- W4387022897 hasRelatedWork W4298840254 @default.
- W4387022897 hasVolume "6" @default.
- W4387022897 isParatext "false" @default.
- W4387022897 isRetracted "false" @default.
- W4387022897 workType "article" @default.